Loading
journalsJournal
The oncologist
The Oncologist is a fully open access monthly journal from Oxford University Press and the Society for Translational Oncology, aimed at translating research into better multidimensional care for cancer patients.
Also called: OncologistThe OncologistThe oncologist (Dayton, Ohio)
Overview
The Oncologist describes itself as dedicated to translating the latest research developments into the best multidimensional care for cancer patients, spanning basic science, translational research, clinical practice and socioeconomic and psychosocial factors across oncology and haematology. It publishes reviews, original studies and commentaries across more than thirty subject areas, from breast and lung cancer to immuno-oncology, paediatric oncology and medical ethics. Since 2022 it has been published by Oxford University Press for the Society for Translational Oncology as a peer-reviewed, fully open access, online-only journal with twelve issues a year; articles are published under CC BY or CC BY-NC licences with an article processing charge (society members receive a discount). It began in 1996 with AlphaMed Press in Dayton, Ohio; print ceased with volume 25 in 2020 (NLM Catalog).
Publisher
Oxford University Press · Society for Translational Oncology
Scope
clinical and translational oncology
Website
Access model
open access
Founded
1996
ISSN
1083-7159
observational2019111 citations
Cannabis Impacts Tumor Response Rate to Nivolumab in Patients with Advanced Malignancies
One technology page on OnCo cites this paper by its DOI; this record gives the citation a page of its own so a reader can follow it without leaving OnCo. Read the abstract above alongside the citing page listed under Related; the record was created automatically from the Europe PMC entry and its figures have not been checked by hand.
observational2013893 citations
The financial toxicity of cancer treatment: a pilot study assessing out-of-pocket expenses and the insured cancer patient's experience
One term page on OnCo cites this paper by its DOI; this record gives the citation a page of its own so a reader can follow it without leaving OnCo. Read the abstract above alongside the citing page listed under Related; the record was created automatically from the Europe PMC entry and its figures have not been checked by hand.
Daniel Serin
Representative of Institut Sainte Catherine to the Organisation of European Cancer Institutes
Cancer centre representation (OECI)
Daniel Serin represents Institut Sainte Catherine in the Organisation of European Cancer Institutes, which lists the organisation among its members in France.
Jaime Feliu
Head of Medical Oncology, Hospital Universitario La Paz
Medical oncologyGastrointestinal cancersGeriatric oncology
Heads medical oncology at La Paz with a focus on gastrointestinal and older-patient oncology.
Julian Adams
President and CEO
Drug discoveryProteasome inhibitorsMultiple myeloma
Medicinal chemist who led the discovery of the proteasome inhibitor bortezomib and now heads Stand Up To Cancer as President and CEO.
Robert Figlin
Interim Director of Cedars-Sinai Cancer
Medical oncologyCancer centre leadershipTranslational research
Medical oncologist who has led Cedars-Sinai Cancer in Los Angeles as Interim Director since March 2025.
Thomas P. Loughran Jr.
Director, UVA Comprehensive Cancer Center
Cancer centre leadershipAcademic medicine
Director who leads the UVA Comprehensive Cancer Center in Charlottesville, Virginia's first NCI-designated comprehensive cancer centre.
Yasuhiro Fujiwara
Chief Executive
Drug regulationMedical oncologyRegulatory science
Medical oncologist who heads Japan's Pharmaceuticals and Medical Devices Agency, the national drug and device regulator.
observationalThe oncologist 2019111 citations
Cannabis Impacts Tumor Response Rate to Nivolumab in Patients with Advanced Malignancies
One technology page on OnCo cites this paper by its DOI; this record gives the citation a page of its own so a reader can follow it without leaving OnCo. Read the abstract above alongside the citing page listed under Related; the record was created automatically from the Europe PMC entry and its figures have not been checked by hand.
observationalThe oncologist 2013893 citations
The financial toxicity of cancer treatment: a pilot study assessing out-of-pocket expenses and the insured cancer patient's experience
One term page on OnCo cites this paper by its DOI; this record gives the citation a page of its own so a reader can follow it without leaving OnCo. Read the abstract above alongside the citing page listed under Related; the record was created automatically from the Europe PMC entry and its figures have not been checked by hand.
Similar pages
- JournalCancer investigation
Shares Julian Adams, PubMed & Europe PMC.
- JournalJournal of geriatric oncology
Shares Jaime Feliu, PubMed & Europe PMC.
- JournalInternational journal of cancer
Shares Robert Figlin, PubMed & Europe PMC.